Zhittya Genesis Medicine Announces: Landmark fMRI Study Reveals 21.2% Boost in Brain Blood Flow in Parkinson’s Patient Following Six Months of Intranasal FGF-1 Therapy Groundbreaking fMRI study that showed a 21.2% increase in brain blood flow in a Parkinson’s patient after six months of intranasal FGF1 therapy.

Autism: Is This a Vascular Disease and Would Therapeutic Angiogenesis Be a Potential Treatment? LAS VEGAS, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Dr. Jack Jacobs, Chief Science Officer of Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), will be presenting at the online AutismOne...

MagTrack Technology Opens Doors for Independent Operation of Smartphones, Computers, Other Devices for Wheelchair Users JACKSONVILLE, Fla., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Brooks Rehabilitation is pleased to announce the MagTrack study, a collaborative research endeavor between Brooks and the Georgia Tech School of...

ENT and Allergy Associates(R) Announce ImThera Medical Clinical Study TARRYTOWN, N.Y., May 28, 2015 (GLOBE NEWSWIRE) -- The following is a message from Dr. Ofer Jacobowitz, partner of ENT and Allergy Associates: Sleep apnea is a serious and dangerous disease where...